Pembrolizumab‐Induced Morphea in a Patient With Metastatic Urothelial Carcinoma
Matthew A Drescher, Douglas W Murray, Douglas J Grider, Kalyani Sen · 2026
Read Pembrolizumab‐Induced Morphea in a Patient With Metastatic Urothelial Carcinoma by Matthew A Drescher, Douglas W Murray, Douglas J Grider, Kalyani Sen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13392509.txt.
Description
Matthew A Drescher and colleagues report morphea, a hardening skin condition, arising in a 59-year-old woman treated with the immune drug pembrolizumab for kidney-area urothelial cancer that had spread. She had earlier received chemoradiation and surgery for a high-grade tumour of the right renal pelvis. The skin change appeared about eighteen months into immunotherapy.
She developed violet, thickened plaques on her legs along with tingling sensations. Biopsies showed thickened collagen bundles and inflammation around small vessels, and magnetic resonance imaging ruled out a deeper related condition affecting the tissue under the skin. Treatment paired methotrexate with steroid creams and brought partial improvement. The authors warn that as checkpoint drugs spread in urology practice, rare skin reactions of this kind need prompt recognition.
Catalog record
| CREATOR | Matthew A Drescher, Douglas W Murray, Douglas J Grider, Kalyani Sen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18508 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |